Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts.
Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, Stamoulis P, Goudevenou K, Prados A, Tzaferis C, Ntafis V, Vamvakaris I, Kaniaris E, Vachlas K, Sepsas E, Koutsopoulos A, Potaris K, Tsoumakidou M.
Kerdidani D, et al. Among authors: tsoumakidou m.
J Exp Med. 2022 Feb 7;219(2):e20210815. doi: 10.1084/jem.20210815. Epub 2022 Jan 14.
J Exp Med. 2022.
PMID: 35029648
Free PMC article.